Kronos Bio Inc (NASDAQ:KRON) currently has a daily average trading volume of 147.75K but it saw 1345508 shares traded in last market. With a market cap of 61.55M USD, the company’s current market price of $1.02 came rising about 8.50 while comparing to the previous closing price of $0.94. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.60 and as low as $0.69. In the recent trading on the day, stock has struck highest price mark of $0.97 while lowest mark touched by it was $1.06.
Taking a look at 20-day trading activity of Kronos Bio Inc (KRON) gives us an average price of $0.8966, while its current price level is -36.25% below from 52-week high level whereas it is 47.83% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.9350 while that of 200 days or SMA-200 reads an average of $1.0467. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.63% during that period while stretching the period over a month that decreases to 6.68%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 60.76 which implies that the stock is in neutral territory.
Piper Sandler downgraded its recommendation for the stock as a “Neutral” from “Overweight” on November 14, 2024 while assigning a price target range of $6-$1. Berenberg issued its recommendations for the stock as it initiated the price target for the stock is $12.
Over the week, KRON’s stock price is moving 6.24% up while it is 7.37% when we observe its performance for the past one month. Year-to-date it is -18.40% down and over the past year, the stock is showing a downside performance of -15.70%.
Currently, Kronos Bio Inc’s total number of outstanding shares is 60.34M. Company’s return on investment (ROI) stands at -64.03% and return on equity (ROE) at -59.08%. Stock’s beta reads 1.84. Stock has a price to book (P/B) ratio of 0.55 while price to sale or P/S ratio amounts to 6.24. Its return on asset (ROA) is -44.11% on average.
